ramipril 1.25mg tablets
pliva pharma ltd - ramipril - oral tablet - 1.25mg
ramipril 2.5mg tablets
sigma pharmaceuticals plc - ramipril - oral tablet - 2.5mg
ramipril 2.5mg tablets
apc pharmaceuticals & chemicals (europe) ltd - ramipril - oral tablet - 2.5mg
ramipril 2.5mg capsules
ennogen pharma ltd - ramipril - oral capsule - 2.5mg
ramipril 5mg capsules
ennogen pharma ltd - ramipril - oral capsule - 5mg
ramipril 10mg capsules
ennogen pharma ltd - ramipril - oral capsule - 10mg
ramipril 10mg capsules
de pharmaceuticals - ramipril - oral capsule - 10mg
ceftazidime 1g, powder for solution for injection/infusion
mip pharma gmbh - ceftazidime - powder for solution for injection/infusion - 1g - antibacterials for systemic use. third-generation cephalosporins - it is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia - broncho-pulmonary infections in cystic fibrosis - bacterial meningitis - chronic suppurative otitis media - malignant otitis externa - complicated urinary tract infections - complicated skin and soft tissue infections - complicated intra-abdominal infections - bone and joint infections - peritonitis associated with dialysis in patients on capd
clomipramine hydrochloride capsule
american health packaging - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomipramine hydrochloride 25 mg - clomipramine hydrochloride capsules usp are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (ocd). the obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning, in order to meet the dsm-iii-r (circa 1989) diagnosis of ocd. obsessions are recurrent, persistent ideas, thoughts, images, or impulses that are ego-dystonic. compulsions are repetitive, purposeful, and intentional behaviors performed in response to an obsession or in a stereotyped fashion, and are recognized by the person as excessive or unreasonable. the effectiveness of clomipramine for the treatment of ocd was demonstrated in multicenter, placebo-controlled, parallel-group studies, including two 10-week studies in adults and one 8-week study in children and adolescents 10 to 17 years of age. patients in all studies had moderate-to-severe ocd (dsm-iii), with mean baseline ratings on the yale-brown obsessive com
clomipramine hydrochloride capsule
pd-rx pharmaceuticals, inc. - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomipramine hydrochloride 25 mg - clomipramine hydrochloride capsules are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (ocd). the obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning, in order to meet the dsm-iii-r (circa 1989) diagnosis of ocd. obsessions are recurrent, persistent ideas, thoughts, images, or impulses that are ego-dystonic. compulsions are repetitive, purposeful, and intentional behaviors performed in response to an obsession or in a stereotyped fashion, and are recognized by the person as excessive or unreasonable. the effectiveness of clomipramine hydrochloride capsules for the treatment of ocd was demonstrated in multicenter, placebo-controlled, parallel-group studies, including two 10-week studies in adults and one 8-week study in children and adolescents 10 to 17 years of age. patients in all studies had moderate-to-severe ocd (dsm-iii), with mean baseline ratings on the yale-